Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control
Completed · Not applicable · Has a placebo group
Conditions studied: Pancreas Cancer, Biliary Tract Cancer
In brief
This is a randomized study of surgery plus chemical nerve block versus surgery plus placebo for pain control in subjects with pancreatic cancer.
Key facts
- Study ID
- NCT02002806
- Run by
- Indiana University
- People needed
- 150
- Starts
- 2012-01-01
- Expected to finish
- 2019-06-01
- Last updated by the study team
- 2019-08-16
Who can join
Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- This study will be offered to all patients scheduled to undergo open or laparoscopic operative resection of a presumed pancreatic (any location; i.e., head, body, or tail) or distal biliary tract cancer.
- Physiologic suitability for major abdominal surgery
- Aged 18 years and older
- Written informed consent
- Ability to understand and comply with study guidelines.
You may not qualify if…
- Pregnancy
- Previous, preoperative celiac nerve block
- Neoadjuvant chemotherapy or radiation therapy
- Incomplete tumor resection (R2 resection, grossly positive resection margin)
- Presumed ampullary or duodenal cancer based on preoperative work-up or intraoperative findings
- Benign tumors, neuroendocrine tumors, soft tissue tumors based on preoperative work-up or intraoperative findings
- Known metastatic disease
Where it is running
- Indiana University — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.